| Original language | English (US) |
|---|---|
| Pages (from-to) | E182-E184 |
| Journal | Rheumatology (United Kingdom) |
| Volume | 62 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 1 2023 |
ASJC Scopus subject areas
- Rheumatology
- Pharmacology (medical)
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Rheumatology (United Kingdom), Vol. 62, No. 6, 01.06.2023, p. E182-E184.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Association between disability scores and opioid use in patients with psoriatic arthritis and ankylosing spondylitis
AU - Ogdie, Alexis
AU - Hwang, Mark
AU - Pedro, Sofia
AU - Veeranki, Phani
AU - Yi, Esther
AU - Hass, Steven
AU - Michaud, Kaleb
N1 - Funding Information: This study was sponsored by Novartis Pharmaceuticals Corporation, East Hanover, NJ. Funding Information: Disclosure statement: A.O. has received consulting fees from Amgen, AbbVie, Bristol Myers Squibb, Celgene, Corrona, Gilead, GSK, Happify Health, Janssen, Lilly, Novartis, Pfizer and UCB and has received grant support from the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases, Rheumatology Research Foundation, National Psoriasis Foundation, Pfizer (University of Pennsylvania), Amgen (FORWARD Data Bank) and Novartis (FORWARD Data Bank). M.H. has received consulting fees from Novartis Pharmaceuticals Corporation and has received grant support from University of Texas Health Science Center at Houston (UTHealth) Center of Clinical and Translational Sciences KL2 program. S.P. is an employee of FORWARD, the National Data Bank for Rheumatic Diseases. P.V. was an employee of PRECISIONheor at the time the work was performed. E.Y. is an employee of Novartis Pharmaceuticals Corporation. S.H. receives consulting fees from Novartis Pharmaceuticals Corporation. K.M. has received grant funding from the Rheumatology Research Foundation. Acknowledgements
PY - 2023/6/1
Y1 - 2023/6/1
UR - http://www.scopus.com/inward/record.url?scp=85160968063&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85160968063&partnerID=8YFLogxK
U2 - 10.1093/rheumatology/keac673
DO - 10.1093/rheumatology/keac673
M3 - Letter
C2 - 36469081
AN - SCOPUS:85160968063
SN - 1462-0324
VL - 62
SP - E182-E184
JO - Rheumatology (United Kingdom)
JF - Rheumatology (United Kingdom)
IS - 6
ER -